InMode/$INMD
1D1W1MYTD1Y5YMAX
Capital at risk
About InMode
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
- Ticker
- $INMD
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 660
- Headquarters
- Yokne'am, Israel
- Website
- www.inmodemd.com
InMode Metrics
BasicAdvanced
$851M
12.17
$1.22
1.87
-
Price and volume
Market cap
$851M
Beta
1.87
52-week high
$16.74
52-week low
$12.72
Average daily volume
470K
Financial strength
Current ratio
8.183
Quick ratio
6.869
Long term debt to equity
0.707
Total debt to equity
0.707
Profitability
EBITDA (TTM)
71.147
Gross margin (TTM)
76.52%
Net profit margin (TTM)
20.69%
Operating margin (TTM)
18.81%
Effective tax rate (TTM)
14.77%
Revenue per employee (TTM)
$570,000
Management effectiveness
Return on assets (TTM)
6.17%
Return on equity (TTM)
12.33%
Valuation
Price to earnings (TTM)
12.167
Price to revenue (TTM)
2.459
Price to book
1.39
Price to tangible book (TTM)
1.39
Price to free cash flow (TTM)
11.164
Free cash flow yield (TTM)
8.96%
Free cash flow per share (TTM)
1.327
Growth
Revenue change (TTM)
-6.71%
Earnings per share change (TTM)
-51.99%
3-year revenue growth (CAGR)
-8.99%
3-year earnings per share growth (CAGR)
-17.01%
What the Analysts think about InMode
Analyst ratings (Buy, Hold, Sell) for InMode stock.
Analyst projections of the future price of InMode stock.
Bulls say / Bears say
InMode’s Q2 2026 revenue beat analyst estimates, with $95.59 million reported against a consensus forecast of $93.03 million, marking a 3.2% upside surprise. (Reuters)
In March 2026, InMode announced a new share repurchase program authorizing the buyback of up to approximately 6.38 million shares, demonstrating management’s confidence in the company’s valuation. (Reuters)
In June 2026, InMode confirmed receipt of an unsolicited $16.20 per share take-private proposal from a group led by its CEO, representing a significant premium to the trading price at the time. (Thomson Reuters)
InMode’s Q2 2026 revenue remained flat at $95.6 million, unchanged from Q2 2025, indicating stagnation in core equipment and consumables sales year-over-year. (Reuters)
GAAP net income for Q2 2026 declined 36.2% year-over-year to $17.1 million, reflecting pressure on profitability and margin compression. (Reuters)
Wall Street’s median 12-month price target of $15.00 is roughly 2.4% below the August 4 closing price of $15.37, suggesting limited upside from current levels. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 29 Aug 2026.
InMode Financial Performance
Revenues and expenses
InMode Earnings Performance
Company profitability
Upcoming events
No upcoming events
InMode News
AllArticlesVideos
Steel Partners Holdings L.P. Issues Letter to InMode Ltd.
Business Wire2 months ago
Steel Partners Offers to Acquire InMode for $16.75 Per Share in Cash
Business Wire2 months ago
Securities Fraud Investigation Into InMode Ltd. (INMD) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Business Wire2 months ago
Funds containing InMode
AllEURUSDGBP
Fund name | Fund size | $INMD weighting |
|---|---|---|
iShares Ageing Population€AGED | €822M | 0.08% |
iShares MSCI World Small Cap$WSML | $9B | 0.01% |
iShares MSCI World Small Cap€IUSN | €7.8B | 0.01% |
iShares MSCI World Small Cap£WLDS | £6.7B | 0.01% |
SPDR MSCI All Country World IM€SPYI | €7.5B | 0.00% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.